Title of talk: Translation of Healthcare Innovations: Lessons Learned from the US and Emory University
Speaker: Dr. Todd Sherer, Executive Director, Office of Technology Transfer, Emory University
Date: 01 June 2022 | Time: 5:30 pm IST | 8:00 am EST
Read the full event report here: ToddSherer_Event Report
Registration Link: https://tinyurl.com/techex-1june
Please note: The zoom link to join the event will be emailed to registered participants a day before the event. Please check your spam folder if you do not receive the link in your inbox.
Abstract: Since the creation of the federal laboratory system in the US, in the years following WWII, the federal government has emerged as the primary funding source of research at universities. In FY21, $598M of research awards at Emory were from the Federal Government out of a total of $895M (nearly 70%). This ratio of federal funding is typical of research intensive universities across the country. Decades of AUTM Licensing Survey data demonstrate the clear correlation between the level of research funding and the number of new inventions. Federal funding and the passage of the Bayh-Dole Act in 1980 have driven the culture of technology transfer in the US. The US also has a very mature venture capital industry as well as other investment markets. Despite this robust ecosystem, gaps still exist in the funding pathway for many startups and for identifying management talent. Startups tend to represent 20-30% of the numbers of licenses executed by academic technology transfer offices. Dr. Sherer will discuss the challenges and opportunities learned from his 30 year career in supporting the transfer, funding, and development of new technology.
About the speaker**:
Dr. Todd Sherer is the Associate Vice President of Research, and Executive Director for the Office of Technology Transfer at Emory University. He has worked extensively with researchers to translate their promising scientific and medical discoveries into new products that benefit society. This crucial activity helps assure that research is translated into practical applications, including new life-saving medical products that benefit the public who helped to fund it. He has helped pioneer new funding models to support the translation of research and worked globally to identify, test, and implement best practices to increase the impact of academic technology commercialization. Todd has also worked with colleagues to affect federal policy and guidelines that address new intellectual property flowing from federally-funded research.
He held similar roles at Oregon Health & Science University, the University of Oregon, and Washington State University. He received his PhD in Pharmacology/Toxicology from Washington State University and a BS degree from Oregon State University. He is a Past President of the Association of University Technology Managers (AUTM), the professional association representing more than 3,000 technology transfer professionals from more than 30 countries. Todd is a Registered Patent Agent (RPA) with the United States Patent and Trademark Office. He is also a Certified Licensing Professional (CLP™) and a Registered Technology Transfer Professional (RTTP).
** Bio taken from: https://www.ott.emory.edu/about/contact/staff.html
